Pre-reimbursement: early assessment for coverage decisions
نویسندگان
چکیده
منابع مشابه
“Budget Impact Analyses”: a practical policy making tool for drug reimbursement decisions
Increasing accessibility and affordability of healthcare services has been considered as an important policy objective since the beginning of 1980s in Iran. However, current 60- 70% health care out-of-pocket payments create a barrier to an equal access to quality health services, especially in terms of new medicines which affects equity issues and "health" in Iran. Currently, health insurance o...
متن کامل“Budget Impact Analyses”: a practical policy making tool for drug reimbursement decisions
Increasing accessibility and affordability of healthcare services has been considered as an important policy objective since the beginning of 1980s in Iran. However, current 60- 70% health care out-of-pocket payments create a barrier to an equal access to quality health services, especially in terms of new medicines which affects equity issues and "health" in Iran. Currently, health insurance o...
متن کاملToward evidence-based assessment for coverage and reimbursement of laboratory-based diagnostic and genetic tests.
Despite the pervasiveness of laboratory tests and their importance to medicine, evidence for their appropriate use often is very limited. In this article, we argue for a fundamental restructuring of the process by which laboratory tests are evaluated and reimbursed. We present an approach that would promote more evidence- based appraisals for laboratory tests. In addition, we urge that coverage...
متن کاملPaying for outcomes: innovative coverage and reimbursement schemes for pharmaceuticals.
available at: http://www.ncbi.nlm.nih.gov/pubmed/12606142. Accessed September 25, 2009. 7. Baker LC, Atlas SW, Afendulis CC. Expanded use of imaging technology and the challenge of measuring value. Health Aff. (Millwood). 2008;27(6):1467-478. 8. Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 200...
متن کاملChallenges in Using MCDA for Reimbursement Decisions on New Medicines?
Multicriteria decision analysis (MCDA) is attracting considerable interest as a tool to assist decision makers faced with the challenge of considering a range of relevant factors when making their decision. The Scottish Medicines Consortium (SMC) is a long-established national health technology assessment (HTA) agency providing guidance to the health service on all new medicines. The stated cri...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Wiener Medizinische Wochenschrift
سال: 2019
ISSN: 0043-5341,1563-258X
DOI: 10.1007/s10354-019-0683-1